Literature DB >> 6861652

[Diphtheria immunity and its epidemiological significance].

P Naumann, H J Hagedorn, R Paatz.   

Abstract

Indirect haemagglutination test for antitoxic diphtheria antibodies was performed on 3503 sera of persons of all age groups. The results demonstrate that a high percentage of juveniles and adults with less than 0.01 IU/ml has either no (48.9% for juveniles, 35.6% for adults) or at 0.01-0.09 IU/ml only insufficient immunological protection (30% and 41%, respectively) against diphtheria and its toxic effects. But even among children up to 14 years of age, 28.5% are completely without and 20.5% without reliably protective antitoxic immunity, despite a high rate of immunization. There is thus a dangerously high epidemic potential of susceptible persons in the population of the Federal Republic of Germany. To erect a barrier of immunity against epidemic spread requires not only immunization of all children, but also re-immunization every five to six years, plus immunization of juveniles and young adults among a selected group with, at present, highest risk of infection. For this purpose there is a diphtheria toxoid of Behringwerke for adults with only 5 IU toxoid/0.5 ml, which, however, after single application produced an antitoxic immunity (greater than or equal to 0.1 IU/ml) in previously sensitized subjects (17 of 49). Of 32 primary seronegative persons 14 reacted to two injections, while a further 18 (36.7%) had no immune response within six weeks even after second injection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861652     DOI: 10.1055/s-2008-1069698

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  8 in total

1.  Determination of diphtheria toxin neutralizing antibody titers with a cell protein synthesis inhibition assay.

Authors:  E Padovan; E Papini; R Rappuoli; C Montecucco
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

2.  Boostering antitoxic diphtheria immunity in adults.

Authors:  H M Hasselhorn; F Hofmann; F W Tiller
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

3.  Diphtheria immunity in Flanders.

Authors:  C Matheï; P Van Damme; P Bruynseels; H Goossens; R Vranckx; A Meheus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

4.  Immunity against diphtheria in adults in Poland.

Authors:  A Galazka; B Kardymowicz
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

5.  A multicentre serosurvey on diphtheria immunity in a French population of 1004 subjects.

Authors:  F Ballereau; I Schrive; A Fisch; M Speich; H Laurichesse; S Tournade; M Rey
Journal:  Eur J Epidemiol       Date:  1998-07       Impact factor: 8.082

6.  Partial in vivo response to corticosteroid treatment in common variable immune deficiency.

Authors:  V Wahn; H Grosse-Wilde; H Rosin; C Carls; U Göbel
Journal:  Infection       Date:  1985 Jan-Feb       Impact factor: 3.553

Review 7.  Diphtheria: changing patterns in the developing world and the industrialized world.

Authors:  A M Galazka; S E Robertson
Journal:  Eur J Epidemiol       Date:  1995-02       Impact factor: 8.082

8.  Decline of serologic immunity to diphtheria, tetanus and pertussis with age suggested a full life vaccination in mainland China.

Authors:  Dandan Liu; Xiaoping Cheng; Shi Wei; Lin Yuan; Changhui Chen; Kaihu Yao
Journal:  Hum Vaccin Immunother       Date:  2021-01-30       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.